HARP Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Harpoon Therapeutics to Merck Jan 8, 2024 09:25AM
HARP Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Harpoon Therapeutics to Merck Jan 8, 2024 09:25AM
Harpoon Therapeutics Inc. (HARP) Announces Up to $150 Million Private Placement Oct 23, 2023 07:18AM
Harpoon Therapeutics Announces Up to $150 Million Private Placement Oct 23, 2023 07:17AM
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in August Aug 3, 2023 07:30AM


Aug 2, 2022 07:30AM Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
Aug 2, 2022 07:30AM Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
Apr 7, 2022 07:30AM Harpoon Therapeutics to Participate in Canaccord Genuity Horizons in Oncology Virtual Conference
Apr 7, 2022 07:30AM Harpoon Therapeutics to Participate in Canaccord Genuity Horizons in Oncology Virtual Conference
Mar 23, 2022 08:48AM Harpoon Therapeutics (HARP) PT Lowered to $14 at Canaccord Genuity
Aug 3, 2021 04:05PM Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
Aug 3, 2021 04:05PM Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
Aug 5, 2020 07:30AM Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
Aug 5, 2020 07:30AM Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
Nov 22, 2019 10:59AM Harpoon Therapeutics (HARP) PT Raised to $26 at Canaccord Genuity
Jul 31, 2019 04:05PM Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
Jul 31, 2019 04:05PM Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
Mar 5, 2019 06:16AM Canaccord Genuity Starts Harpoon Therapeutics (HARP) at Buy
Feb 8, 2019 11:27AM Harpoon Therapeutics (HARP) IPO Opens Flat